Showing 1 - 10 of 15
Persistent link: https://www.econbiz.de/10011899711
The existence of reference price effects in consumer decision making is well documented in prior research, but few studies focus on its implications for firms' strategic behavior. Using a competitive model, we address this gap by examining how firms' product positioning and pricing strategies in...
Persistent link: https://www.econbiz.de/10012855091
In this paper, we extend the understanding of versioning strategy of an information goods monopolist and provide new insights on when versioning is optimal. To do so, we derive the optimal product line or versions of an information good and the corresponding prices. By relaxing common...
Persistent link: https://www.econbiz.de/10012980733
Persistent link: https://www.econbiz.de/10011874048
Persistent link: https://www.econbiz.de/10012504964
The accumulated evidence indicates that pure revenue models, such as free-access models and pure subscription fee based models, are not sufficient to support the survival of online information sellers. Hence, hybrid models based on a combination of subscription fees and advertising revenues are...
Persistent link: https://www.econbiz.de/10012751613
Public cloud capacity providers offer various pricing models namely, on-demand capacity instances, reserved capacity instances, and a hybrid of these two pricing models. The buyer firms seeking cloud solutions not only source their requirements from the public cloud providers but also invest in...
Persistent link: https://www.econbiz.de/10012893768
Two commonly used pricing models in the supplier-retailer setting are the agency pricing model and the wholesale pricing model. In the agency pricing model, the supplier sets the price, whereas in the wholesale pricing model, the price is set by the retailer. In this paper, we focus on the...
Persistent link: https://www.econbiz.de/10012864849
Persistent link: https://www.econbiz.de/10012805178
Problem Definition: Healthcare expenditures are increasing worldwide, and spending on pharmaceutical drugs is a major contributor to this trend. Many countries are responding by implementing external reference pricing (ERP) to contain drug prices, which is a commonly used policy by countries...
Persistent link: https://www.econbiz.de/10013314648